Search Results 141-150 of 13201 for Livedo

  1. Study Of GI-102 And PD-1 In Glioblastoma - Mayo Clinic

    The purpose of this study to assess pharmacodynamic (PD) changes in tumor tissue. Participation eligibility. Participant eligibility includes age, gender, type ...

  2. A Study to Improve Cardiovascular Health Among African Americans within Faith Communities - Mayo Clinic

    About this study. The purpose of this study is to apply a community-based participatory research (CBPR) approach to rigorously refine and test the ...

  3. Non Clinical Trials - Mayo Clinic Research

    Duvelisib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Chemotherapy drugs, such as CC-486, cyclophosphamide, ...

  4. A Study to Assess Frailty and Its Impact on Patients with Pulmonary Hypertension - Mayo Clinic

    The purpose of this study is to evaluate the prevalence and effect of frailty in patients referred to pulmonary hypertension (PH) clinic at our institution.

  5. Non-Hodgkin's Lymphoma Clinical Trials - Mayo Clinic Research

    Duvelisib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Chemotherapy drugs, such as CC-486, cyclophosphamide, ...

  6. Medibio Depression Monitoring Study - Clinical Trials

    The purpose of this study is to explore whether Medibio's system can provide objective measures of response to standard medication treatment for unipolar ...

  7. A Study to Evaluate the Effectiveness and Safety of Virtual Reality in the Treatment of Functional Dyspepsia - Mayo Clinic

    Inclusion Criteria: Adult patients, men and women ages 18-75. Symptoms of dyspepsia thought to represent FD. Meeting Rome IV criteria.

  8. Longitudinal Characterization and Genetic Analysis of Pediatric-Onset Morphea - Mayo Clinic

    About this study. The purpose of this project is to determine the genetic causes of disease and establish accurate clinical indicators and biomarkers of ...

  9. Study of Safety and Efficacy of Iberdomide (CC-220) and CC-99282 Combined With R-CHOP to Treat Lymphoma - Mayo Clinic

    About this study. The primary objective of Part 1 of this study is to define the maximum tolerated dose (MTD) and/or the recommended Phase 2 dose (RP2D) of ...

  10. A Phase 2, Baseline-Controlled Study Evaluating the Safety and Efficacy of PTX-022 (Sirolimus) Topical Gel 3.9% in the Treatment of Cutaneous Venous Malformations - Mayo Clinic

    A Phase 2, Baseline-Controlled Study Evaluating the Safety and Efficacy of PTX-022 (Sirolimus) Topical Gel 3.9% in the Treatment of Cutaneous Venous ...